News



June 14 2019 web conference presentation
14/06/2019 - AB Science web conference presentation

Positive IDMC recommendation following interim analysis in pancreatic cancer
12/06/2019 - AB Science announces the positive recommendation of IDMC following the interim analysis of AB12005 study in the first-line treatment of pancreatic cancer

Updated corporate overview
10/06/2019 - AB Science is providing an updated coporate overview of the Company

Upcoming news flow
10/06/2019 - AB Science is providing the upcoming news flow of the Company

Summary of the webconference held on June 5, 2019
05/06/2019 - AB Science is providing a summary of the web conference held on 5 June, 2019

June 5 2019 web conference presentation
05/06/2019 - AB Science web conference presentation (Part 2)

Summary of the webconference held on June 4, 2019
04/06/2019 - AB Science is providing a summary of the web conference held on 4 June, 2019

June 4 2019 web conference presentation
04/06/2019 - AB Science web conference presentation (Part 1)

Web conference on June 4 and 5, 2019
30/05/2019 - AB Science will hold a web conference on its outlook for 2019 onJune 4 and 5, 2019 from 5.30 pm to 7pm CET

Lifting of the ANSM clinical hold
28/05/2019 - AB Science announces the lifting of the ANSM clinical hold

Annual financial results as of 31 December, 2018
30/04/2019 - AB Science reports its annual financial results as of 31 December 2018

Presentation of new masitinib preclinical data in ALS at the 2019 Muscular Dystrophy Association Conference
16/04/2019- AB Science presented new preclinical data for masitinib in ALS at the 2019 Muscular Dystrophy Association Conference. Conference

Acceptance of abstract for oral presentation at the 2019 Muscular Dystrophy Association Conference
21/03/2019 - AB Science announces acceptance of abstract for oral presentation at the 2019 Muscular Dystrophy Association Conference